Updated: July 4, 2021 11:56:09 pm
The Union government has created two new facilities to facilitate and expedite the testing and pre-release certification of Covid-19 vaccines.
These Central Drugs Laboratories have been set up by the Department of Biotechnology at its autonomous research institutes — the National Centre for Cell Science (NCCS), Pune, and the National Institute of Animal Biotechnology (NIAB), Hyderabad.
Both cities are vaccine manufacturing hubs. While Covishield-manufacturer Serum Institute of India is headquartered in Pune, Bharat Biotech, which makes Covaxin, is based out of Hyderabad.
The country currently has only one Central Drugs Laboratory, at Kasauli in Himachal Pradesh.
The new labs, set up with funding support from the PM-CARES fund, will carry out batch testing and quality control of vaccines, said a statement issued by the Ministry of Science and Technology.
The facilities are expected to test approximately 60 batches of vaccines per month. “The facilities are geared up to test existing Covid-19 vaccines and other newer Covid-19 vaccines as per demand of the nation. This will not only expedite the vaccine manufacture and supply but also be logistically convenient considering that both Pune and Hyderabad are the two vaccine manufacturing hubs,’’ said the statement.
Since the beginning of the Covid-19 pandemic, the Department of Biotechnology has been involved in vaccine development, diagnostics and testing, bio-banking and genomic surveillance, in addition to fundamental research, the statement said.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.